Kate Park / TechCrunch:
ImpriMed, which builds AI-powered drug response prediction tech to help treat cancer in dogs and cats, raised a $23M Series A led by SoftBank Ventures Asia — ImpriMed, a California-based precision medicine startup, builds AI-powered dog cancer treatment technology that helps veterinarians identify …
Checkout latest world news below links :
Tech News ||World News || Latest News || U.S. News
The post ImpriMed, which builds AI-powered drug response prediction tech to help treat cancer in dogs and cats, raised a $23M Series A led by SoftBank Ventures Asia (Kate Park/TechCrunch) appeared first on WorldNewsEra.